Connor, Clark & Lunn Investment Management (CC&L)’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.43M Sell
20,495
-10,587
-34% -$740K 0.01% 952
2025
Q1
$2.28M Buy
31,082
+5,807
+23% +$427K 0.01% 697
2024
Q4
$1.66M Buy
25,275
+7,465
+42% +$489K 0.01% 786
2024
Q3
$1.39M Buy
17,810
+5,022
+39% +$391K 0.01% 777
2024
Q2
$997K Buy
12,788
+2,827
+28% +$220K ﹤0.01% 847
2024
Q1
$675K Sell
9,961
-229
-2% -$15.5K ﹤0.01% 1018
2023
Q4
$686K Sell
10,190
-1,230
-11% -$82.8K ﹤0.01% 964
2023
Q3
$773K Sell
11,420
-405
-3% -$27.4K ﹤0.01% 902
2023
Q2
$846K Buy
11,825
+565
+5% +$40.4K ﹤0.01% 844
2023
Q1
$782K Sell
11,260
-70,498
-86% -$4.89M ﹤0.01% 780
2022
Q4
$5.54M Sell
81,758
-163,718
-67% -$11.1M 0.03% 335
2022
Q3
$13.5M Sell
245,476
-605,306
-71% -$33.2M 0.09% 168
2022
Q2
$56.2M Buy
850,782
+844,177
+12,781% +$55.8M 0.34% 51
2022
Q1
$438K Sell
6,605
-22,925
-78% -$1.52M ﹤0.01% 802
2021
Q4
$1.72M Buy
+29,530
New +$1.72M 0.01% 566
2020
Q3
Sell
-110,350
Closed -$5.84M 933
2020
Q2
$5.84M Buy
+110,350
New +$5.84M 0.04% 270
2019
Q3
Sell
-112,900
Closed -$4.66M 961
2019
Q2
$4.66M Buy
112,900
+76,200
+208% +$3.15M 0.03% 300
2019
Q1
$1.48M Sell
36,700
-40,000
-52% -$1.62M 0.01% 466
2018
Q4
$2.91M Buy
+76,700
New +$2.91M 0.02% 356
2017
Q3
Sell
-126,100
Closed -$4.3M 812
2017
Q2
$4.3M Buy
+126,100
New +$4.3M 0.03% 285
2016
Q4
Sell
-43,044
Closed -$1.41M 891
2016
Q3
$1.41M Sell
43,044
-9,700
-18% -$319K 0.01% 419
2016
Q2
$1.59M Hold
52,744
0.01% 393
2016
Q1
$1.49M Hold
52,744
0.01% 385
2015
Q4
$1.79M Sell
52,744
-5,400
-9% -$183K 0.02% 359
2015
Q3
$1.85M Hold
58,144
0.02% 309
2015
Q2
$1.85M Sell
58,144
-1,000
-2% -$31.9K 0.02% 251
2015
Q1
$2.02M Hold
59,144
0.02% 232
2014
Q4
$2.08M Hold
59,144
0.02% 222
2014
Q3
$2.11M Sell
59,144
-2,000
-3% -$71.5K 0.02% 212
2014
Q2
$2.42M Sell
61,144
-31,800
-34% -$1.26M 0.02% 229
2014
Q1
$3.33M Sell
92,944
-7,600
-8% -$272K 0.02% 209
2013
Q4
$3.17M Sell
100,544
-42,758
-30% -$1.35M 0.02% 205
2013
Q3
$3.83M Buy
+143,302
New +$3.83M 0.03% 133